Kymera Therapeutics, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Kymera Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Kymera Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -229 %, a 42.1% increase year-over-year.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2023 was -211 %, a 38.8% increase from 2022.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2022 was -344 %, a 149% decline from 2021.
  • Kymera Therapeutics, Inc. annual Operating Margin for 2021 was -138 %, a 1.46% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -211 +134 +38.8% Jan 1, 2023 Dec 31, 2023
2022 -344 -206 -149% Jan 1, 2022 Dec 31, 2022
2021 -138 -1.98 -1.46% Jan 1, 2021 Dec 31, 2021
2020 -136 +1.3K +90.5% Jan 1, 2020 Dec 31, 2020
2019 -1.44K Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.